Page last updated: 2024-10-31

molsidomine and Neuroretinitis

molsidomine has been researched along with Neuroretinitis in 1 studies

Molsidomine: A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS.
molsidomine : A member of the class of oxadiazoles that is 1,2,3-oxadiazole substituted by morpholin-4-yl and (ethoxycarbonyl)azanidyl groups at positions 3 and 5, respectively. It is used as a vasodilator drug for the treatment of myocardial ischemic syndrome and congestive heart failure.

Research Excerpts

ExcerptRelevanceReference
"Oral treatment with molsidomine (MSDM), a NO donor, began 24 h before IRBP immunization to the end of the experiments, which resulted in a significant inhibition of the disease by clinical and histopathological criteria."1.31Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response. ( Chung, HT; Kim, YM; Kwak, HJ; Pae, HO; Yang, YS, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kwak, HJ1
Yang, YS1
Pae, HO1
Kim, YM1
Chung, HT1

Other Studies

1 other study available for molsidomine and Neuroretinitis

ArticleYear
Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response.
    Molecules and cells, 2001, Oct-31, Volume: 12, Issue:2

    Topics: Animals; Autoimmune Diseases; Disease Models, Animal; Eye Proteins; Humans; Immunization; Interferon

2001